Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com



CSE Listing(s):

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-12-01-AfriLeaf-Inaugural-Annual-Conference_Website_1.png

AfriLeaf Biosciences’ Inaugural Annual Conference 2020

Tuesday, December 1, 2020 -
8:00am to 12:00pm
2020-12-01-Tech-Tuesday-Best-of-Autumn_Website_1.png

Tech Tuesdays

Tuesday, December 1, 2020 -
4:15pm to 5:00pm
Health-Tech-Thursdays_general_Website_1.png

Health Tech Thursdays

Thursday, December 3, 2020 -
1:15pm to 2:00pm

Advertisement

Publicité